Alison Bigley

2.4k total citations · 1 hit paper
21 papers, 1.4k citations indexed

About

Alison Bigley is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Alison Bigley has authored 21 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Immunology. Recurrent topics in Alison Bigley's work include Angiogenesis and VEGF in Cancer (5 papers), Immunotoxicology and immune responses (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Alison Bigley is often cited by papers focused on Angiogenesis and VEGF in Cancer (5 papers), Immunotoxicology and immune responses (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Alison Bigley collaborates with scholars based in United Kingdom, Singapore and United States. Alison Bigley's co-authors include Stephen R. Wedge, Kevin J. Randall, F. Russell Westwood, Robert C. Scott, Jane Kendrew, Michael Dukes, P.F. Wadsworth, Donald Ogilvie, Graham H.P. Richmond and Rosemary Chester and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Alison Bigley

20 papers receiving 1.3k citations

Hit Papers

ZD6474 inhibits vascular endothelial growth factor signal... 2002 2026 2010 2018 2002 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration.
    2002 702 citations Stephen R. Wedge, Donald Ogilvie et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison Bigley United Kingdom 9 766 558 286 273 198 21 1.4k
Susanna Leskelä Spain 22 577 0.8× 457 0.8× 143 0.5× 154 0.6× 415 2.1× 27 1.4k
Claudio Vernieri Italy 21 781 1.0× 845 1.5× 322 1.1× 203 0.7× 418 2.1× 91 1.8k
Sonia Bergaya France 14 627 0.8× 650 1.2× 308 1.1× 97 0.4× 240 1.2× 15 1.9k
Takao Kamai Japan 25 1.0k 1.3× 566 1.0× 560 2.0× 227 0.8× 357 1.8× 126 2.2k
Chang Hun Rhee South Korea 22 968 1.3× 287 0.5× 196 0.7× 116 0.4× 405 2.0× 34 1.8k
John E. Monahan United States 12 918 1.2× 274 0.5× 561 2.0× 110 0.4× 306 1.5× 18 1.6k
Sujata Persad Canada 19 1.4k 1.8× 385 0.7× 179 0.6× 336 1.2× 303 1.5× 37 2.1k
Nobuya Ishii United States 20 1.4k 1.8× 802 1.4× 601 2.1× 88 0.3× 220 1.1× 49 2.2k
Jason Gay United States 18 653 0.9× 440 0.8× 120 0.4× 189 0.7× 309 1.6× 30 1.6k
Takako Asano Japan 27 1.3k 1.7× 378 0.7× 412 1.4× 227 0.8× 469 2.4× 84 2.1k

Countries citing papers authored by Alison Bigley

Since Specialization
Citations

This map shows the geographic impact of Alison Bigley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Bigley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Bigley more than expected).

Fields of papers citing papers by Alison Bigley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Bigley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Bigley. The network helps show where Alison Bigley may publish in the future.

Co-authorship network of co-authors of Alison Bigley

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Bigley. A scholar is included among the top collaborators of Alison Bigley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Bigley. Alison Bigley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hargreaves, Adam, Simon T. Barry, Alison Bigley, Jane Kendrew, & Sally Price. (2022). Tumours modulate the systemic vascular response to anti‐angiogenic therapy. Journal of Applied Toxicology. 42(8). 1371–1384. 1 indexed citations
2.
Bigley, Christopher, John Waller, Alison Bigley, et al.. (2021). Abstract PO-001: Deep learning-based image analysis of the histological Glasgow Microenvironment Score in patients with colorectal cancer. Clinical Cancer Research. 27(5_Supplement). PO–1.
3.
Hargreaves, Adam, Simon T. Barry, Alison Bigley, Jane Kendrew, & Sally Price. (2021). Tumors modulate fenestrated vascular beds and host endocrine status. Journal of Applied Toxicology. 41(12). 1952–1965. 1 indexed citations
4.
Hargreaves, Adam, Alison Bigley, Sally Price, Jane Kendrew, & Simon T. Barry. (2017). Automated image analysis of intra‐tumoral and peripheral endocrine organ vascular bed regression using ‘Fibrelength’ as a novel structural biomarker. Journal of Applied Toxicology. 37(8). 902–912. 2 indexed citations
5.
David, Kerstin A., et al.. (2016). Digital image analysis of automated mRNA in situ hybridization and immunohistochemistry to quantify HER3 expression in cancer tissues.. Journal of Clinical Oncology. 34(15_suppl). e23172–e23172. 1 indexed citations
6.
Bigley, Alison, et al.. (2016). Using Automated Image Analysis Algorithms to Distinguish Normal, Aberrant, and Degenerate Mitotic Figures Induced by Eg5 Inhibition. Toxicologic Pathology. 44(5). 663–672. 5 indexed citations
7.
Kipar, Anja, David J. Hughes, Nathifa Moyo, et al.. (2014). Gammaherpesvirus infection modulates the temporal and spatial expression of SCGB1A1 (CCSP) and BPIFA1 (SPLUNC1) in the respiratory tract. Laboratory Investigation. 95(6). 610–624. 7 indexed citations
8.
Jones, Huw B., et al.. (2014). Islets of Langerhans from prohormone convertase‐2 knockout mice show α‐cell hyperplasia and tumorigenesis with elevated α‐cell neogenesis. International Journal of Experimental Pathology. 95(1). 29–48. 14 indexed citations
9.
Stamp, Katie, et al.. (2013). Comparison of Computerized Image Analysis with Traditional Semiquantitative Scoring of Perls’ Prussian Blue Stained Hepatic Iron Deposition. Toxicologic Pathology. 41(7). 992–1000. 18 indexed citations
10.
11.
12.
Kelly, Vincent P., Larry G. Higgins, Michael Kelleher, et al.. (2009). Expression and Localization of Rat Aldo-Keto Reductases and Induction of the 1B13 and 1D2 Isoforms by Phenolic Antioxidants. Drug Metabolism and Disposition. 38(2). 341–346. 8 indexed citations
13.
Bigley, Alison, et al.. (2008). Validation of an OptoMotry system for measurement of visual acuity in Han Wistar rats. Journal of Pharmacological and Toxicological Methods. 58(2). 152–152. 5 indexed citations
14.
Westwood, F. Russell, et al.. (2008). Rosuvastatin: Characterization of Induced Myopathy in the Rat. Toxicologic Pathology. 36(2). 345–352. 37 indexed citations
15.
Wilkinson, Robert W., Rajesh Odedra, Simon P. Heaton, et al.. (2007). AZD1152, a Selective Inhibitor of Aurora B Kinase, Inhibits Human Tumor Xenograft Growth by Inducing Apoptosis. Clinical Cancer Research. 13(12). 3682–3688. 278 indexed citations
16.
McKay, Jennifer S., et al.. (2005). A pilot evaluation of the use of tissue microarrays for quantitation of target distribution in drug discovery pathology. Experimental and Toxicologic Pathology. 57(3). 181–193. 8 indexed citations
17.
Westwood, F. Russell, et al.. (2005). Statin-Induced Muscle Necrosis in the Rat: Distribution, Development, and Fibre Selectivity. Toxicologic Pathology. 33(2). 246–257. 153 indexed citations
18.
Wedge, Stephen R., Jane Kendrew, Jon Curwen, et al.. (2004). The VEGF receptor tyrosine kinase inhibitor AZD2171 inhibits VEGF signaling, angiogenesis, and tumor growth in vivo. Cancer Research. 64. 1052–1052. 7 indexed citations
19.
Thomson, Rachel E., Alison Bigley, John R. Foster, et al.. (2004). Tissue-specific Expression and Subcellular Distribution of Murine Glutathione S-transferase Class Kappa. Journal of Histochemistry & Cytochemistry. 52(5). 653–662. 43 indexed citations
20.
Wedge, Stephen R., Donald Ogilvie, Michael Dukes, et al.. (2002). ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration.. PubMed. 62(16). 4645–55. 702 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susanna Leskelä Breakdown of academic impact, for papers by Claudio Vernieri Breakdown of academic impact, for papers by Sonia Bergaya Breakdown of academic impact, for papers by Takao Kamai Breakdown of academic impact, for papers by Chang Hun Rhee Breakdown of academic impact, for papers by John E. Monahan Breakdown of academic impact, for papers by Sujata Persad Breakdown of academic impact, for papers by Nobuya Ishii Breakdown of academic impact, for papers by Jason Gay Breakdown of academic impact, for papers by Takako Asano
Rankless by CCL
2026